MENU
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Viridian Therapeutics (VRDN) Ownership - Who owns Viridian Therapeutics?
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.47B
P/E Ratio
N/A
Total Cash
563.36M
Projected Growth
N/A
Total Debt
21.34M
Revenue
305K
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash/Share
6.90
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
VRDN
Capitalization
1.47B
P/E Ratio
N/A
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash
563M
Total Cash/Share
6.90
Total Debt
21.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
305K
ROE
N/A
Book Value
326M
P/B Ratio
4.51
Cash Flow
N/A
Earnings
-3.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
817K
Current Ratio
11.01
Current Revenue Per Employee
524.48
Dividends Per Share - Security
N/A
EBITDA
-340.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
8.47
Revenue To Assets
-58.92
Shares Held By Institutions
1.92B
Shares Outstanding - Current
81.7M
Total Liabilities
67.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
-5.999
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRDN showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com